NCT04850612 (CODE-CSDH) is a clinical trial of Survey in Chronic Subdural Hematoma, sponsored by University Hospital Plymouth NHS Trust.

Who is sponsoring NCT04850612?

NCT04850612 is sponsored by University Hospital Plymouth NHS Trust.

What drugs are being tested in NCT04850612?

Interventions in NCT04850612: Survey.

What condition does NCT04850612 study?

NCT04850612 studies Chronic Subdural Hematoma.

Is NCT04850612 still recruiting?

NCT04850612 is currently completed. Last updated 17 June 2025.

Last reviewed 2025-06-17 · How we verify

NCT04850612: CODE-CSDH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Defining Core Outcomes and Data Elements (CODE) in Chronic Subdural Haematoma

Completed Last updated 17 June 2025

What this trial tests

trial testing Survey in Chronic Subdural Hematoma in 184 participants. Completed in 1 February 2025.

Timeline

30 April 2021

Primary endpoint
1 November 2024

1 February 2025

Quick facts

Lead sponsor	University Hospital Plymouth NHS Trust
Status	Completed
Study type	OBSERVATIONAL
Enrollment	184
Start date	30 April 2021
Primary completion	1 November 2024
Estimated completion	1 February 2025
Sites	1 location across United Kingdom

Drugs / interventions tested

Survey

Conditions studied

Chronic Subdural Hematoma — all drugs for Chronic Subdural Hematoma →

Sponsor

University Hospital Plymouth NHS Trust

Who can join

18 and older, any sex, with Chronic Subdural Hematoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed at improving reporting in Chronic Subdural Haematoma (CSDH) research studies, through development of a standardised Core Outcome Set (COS), a unified CSDH Definition and set of Data Elements (DE) for reporting. The study design includes a Delphi survey process from two main stakeholder groups: Health-Care Professionals or Researchers (HCPR) and Patients or carers. HCPR, patients and carers will all be invited to complete the survey on the COS, only the HCPR survey will include questions on definition and DE. Results of the Delphi Survey will be discussed at a final consensus meeting before results are confirmed and published.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Study Protocol on Defining Core Outcomes and Data Elements in Chronic Subdural Haematoma.
Holl DC, Chari A, Iorio-Morin C, Dammers R, et al · · 2021 · cited 10× · PMID 34318894 · DOI 10.1093/neuros/nyab268

Verify or expand the search:

Other trials of Survey

Trials testing the same drug.

NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
NCT07294703 — Factors Associated With Breast Cancer Risks and Outcomes · recruiting
NCT07330739 — Kinesiophobia in Women With Stress Urinary Incontinence · active not recruiting
NCT07215039 — Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida · enrolling by invitation
NCT07220096 — Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Pati · recruiting

Other recruiting trials for Chronic Subdural Hematoma

Currently open trials in the same condition.

NCT07245264 — Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH) · Phase 2, PHASE3 · recruiting
NCT07144423 — Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma · NA · recruiting
NCT07324551 — Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center · recruiting
NCT07421453 — Implementation of an Enhanced Recovery Pathway for Burr-hole Drainage in Patients With a Chronic Subdural Hematoma · recruiting
NCT06772740 — Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma · NA · recruiting

Other University Hospital Plymouth NHS Trust trials

Trials by the same sponsor.

NCT07314437 — 5 Minute 'HOT' Trauma CT Rates Of Detection Study · NA · not yet recruiting
NCT07281560 — Opinions, Perceptions, & Thoughts of British Resident Doctors on Orthopaedics · not yet recruiting
NCT07193004 — Quality of Life Improvement After TAVI (QualiTAVI-UK Trial) · not yet recruiting
NCT06665659 — Evaluation of the Eyhance and Zoe Lenses · not yet recruiting
NCT06446297 — Generational Diversity in the Medical Profession · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04850612 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Plymouth NHS Trust
Last refreshed: 17 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04850612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing